Prostate Cancer: From Molecular Diagnosis to Treatment
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: closed (20 December 2024) | Viewed by 3426
Special Issue Editor
Special Issue Information
Dear Colleagues,
Prostate cancer is a multifaceted and biologically highly heterogeneous disease, with widely varying levels of mortality and morbidity. Many patients present with an indolent disease with few symptoms, while others develop a highly aggressive disease that progresses to metastatic carcinoma that is refractory to both hormone therapy and chemotherapy.
This disease is the most common cancer in men and the second leading cause of cancer deaths. Despite the great progress made in the field of prostate cancer research and treatment, further integrated analyses are still required to better understand the biology of prostate cancer and to identify new biomarkers in order to determine the diagnosis, prognosis and targeted therapeutic options for patients.
This Special Issue invites manuscripts analysing the genome, epigenome and transcriptome that are associated with the initiation and progression of prostate cancer from indolent to malignant status, as well as therapeutic responses. In addition, we are interested in publishing analyses of novel target therapies.
Dr. Ida Silvestri
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- molecular profiling
- prostate cancer diagnosis
- precision target therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
